Market Cap

Galenica AG Market Capitalization:

CHF4.87 Billion

CHF as of Jan. 1, 2026

US$6.14 Billion

business Galenica AG Company Profile

Galenica AG Main Stock Listing

SIX: GALE

Market Capitalization History of Galenica AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Distribution
Company Market Cap (USD)
McKesson Corporation $102.42 B
Cencora, Inc. $65.71 B
Cardinal Health, Inc. $48.88 B
Shanghai Pharmaceuticals Holding Co. Ltd $9.44 B
Henry Schein, Inc. $9.32 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Galenica AG market cap

Date Market Cap YoY Change
Jan. 1, 2026 CHF4.87 B 34.02%
Jan. 1, 2025 CHF3.63 B -1.46%
Jan. 1, 2024 CHF3.69 B -2.02%
Jan. 1, 2023 CHF3.76 B 17.90%
Jan. 1, 2022 CHF3.19 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Galenica AG Categories

Switzerland languages Healthcare languages Medical Distribution
Switzerland Healthcare Switzerland Medical Distribution

Stocks & Indices

Galenica AG has the following listings and related stock indices.


Stock: SIX: GALE

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.